MedTrace Logo

A Clinical Test for the Treatment of Multifocal Lung Cancers Using Genome Sequencing

NCT02705404 · Status: TERMINATED · Type: OBSERVATIONAL · Enrollment: 8

Last updated 2022-04-14

No results posted yet for this study

Summary

The investigators are doing this research to see if they can use small tissue samples or fluid to develop a test that will determine if the tissue samples are related or not related to each other. The test will use the patient's DNA, which is part of their unique genetic material that carries the instructions for the body's development and function. Cancer can result from changes in a person's genetic material that causes cells to divide in an uncontrolled way and, sometimes, to travel to other organs. Currently, researchers and doctors know some of the genetic changes that can cause cancer, but they do not know all of the genetic changes that can cause cancer.

Conditions

  • Lung Neoplasms
  • Carcinoma Non-small-cell Lung

Interventions

GENETIC

Multifocal Tissue Banking

Sponsors & Collaborators

Principal Investigators

  • Marie Christine Aubry, MD · Mayo Clinic

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-02-11
Primary Completion
2021-11-16
Completion
2021-11-16

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02705404 on ClinicalTrials.gov